Tools

LEADER 02275cam 2200457 a 4500

001 ocm51097813;

003 OCoLC;

005 20060728141900.0;

008 021130s2002 dcu f000 0 eng c;

035 a| (OCoLC)51097813;

042 a| pcc;

043 a| n-us---;

049 a| ERE$;

074 a| 1008-C;

074 a| 1008-C (online);

074 a| 1008-D (MF);

074 a| 1008-D (online);

086 0 a| Y 1.1/5:107-300;

245 10 a| Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients :b| report together with additional views (to accompany S. 2394).;

260 a| [Washington, D.C. :b| U.S. G.P.O.,c| 2002];

300 a| 22 p. ;c| 24 cm.;

490 1 a| Report / 107th Congress, 2d session, Senate ;v| 107-300;

500 a| Caption title.;

500 a| Distributed to some depository libraries in microfiche.;

500 a| Shipping list no.: 2003-0043-P.;

500 a| "October 8, 2002.";

530 a| Also available via Internet from the GPO Access web site. Addresses as of 12/24/02: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107c̲ongr̲eports&docid=f:sr300.107 (text version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107c̲ongr̲eports&docid=f:sr300.107.pdf (PDF version); current access is available via PURLs.;

610 10 a| United States.t| Federal Food, Drug, and Cosmetic Act.=| ^A511741;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 0 a| Pediatric pharmacologyz| United States.=| ^A5340;

650 0 a| Drug testingx| Law and legislationz| United States.=| ^A261484;

810 1 a| United States.b| Congress.b| Senate.t| Reportv| 107-300.=| ^A495460;

856 41 3| Text version:u| https://purl.fdlp.gov/GPO/LPS25276;

856 41 3| PDF version:u| https://purl.fdlp.gov/GPO/LPS25277z| Adobe Acrobat Reader required;

998 a| 943361;

998 a| u943361;

596 a| 1;

999 a| ASK AT REFERENCE DESKw| SUDOCc| 1i| MQ1663854d| 8/7/2007l| JDOSm| JOYNERr| Ys| Yt| MARCIVEu| 2/4/2004x| BOOKz| JFEDDOCSo| .STAFF. 0;

Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).

Author/creator	United States
Format	Book
Publication Info	[Washington, D.C. : U.S. G.P.O., 2002]
Description	22 p. ; 24 cm.
Supplemental Content	Text version
Supplemental Content	Adobe Acrobat Reader required
Subjects	United States. Federal Food, Drug, and Cosmetic Act. United States. Food and Drug Administration. Pediatric pharmacology--United States. Drugs--Labeling. --Law and legislation. --United States. Drug testing--Law and legislation. --United States.

Series	Report / 107th Congress, 2d session, Senate ; 107-300 United States. Congress. Senate. Report 107-300. ^A495460
General note	Caption title.
General note	Distributed to some depository libraries in microfiche.
General note	Shipping list no.: 2003-0043-P.
General note	"October 8, 2002."
Other forms	Also available via Internet from the GPO Access web site. Addresses as of 12/24/02: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107c̲ongr̲eports&docid=f:sr300.107 (text version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107c̲ongr̲eports&docid=f:sr300.107.pdf (PDF version); current access is available via PURLs.
GPO item number	1008-C
GPO item number	1008-C (online)
GPO item number	1008-D (MF)
GPO item number	1008-D (online)
Govt. docs number	Y 1.1/5:107-300

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	Fed Docs Stacks	ASK AT REFERENCE DESK	✔ Available	Place Hold

Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).

Click here for more information about this title

Availability